At a glance
ClinicalIndex Comparison RecordN/ACompleted· 330 enrolled
Drug / intervention
S-ICD Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
S-ICD® System Clinical Investigation
In Brief
A clinical study evaluating S-ICD System for Tachycardia, Ventricular. Completed, enrolled 330 participants across 33 sites in 4 countries.
Detailed Summary
This clinical study is designed to evaluate the safety and effectiveness of the subcutaneous implantable defibrillator (S-ICD) System.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTachycardia, Ventricular
CountriesNetherlands, New Zealand, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2010
First PostedFeb 2010
Primary CompletionOct 2011
Study CompletionJan 2013
TodayJul 2026
First PostedFeb 8, 2010
Enrollment StartJan 1, 2010
Primary CompletionOct 1, 2011
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.4 years ago
Interventions
S-ICD Systemdevice
The S-ICD System is an implantable technology that uses a subcutaneous pulse generator and subcutaneous electrode system to treat ventricular tachyarrhythmias. The S-ICD System consists of the SQ-RX pulse generator (Model 1010), the Q-TRAK subcutaneous electrode (Model 3010), the Q-TECH programmer (Model 2020), and Q-GUIDE electrode insertion tools (Models 4010 and 4020).